Denali Therapeutics shares owned by Gilder, Gagnon, Howe & Co
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Gilder, Gagnon, Howe & Co
from 13F filings
Historical chart of Gilder, Gagnon, Howe & Co investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Gilder, Gagnon, Howe & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $26M | 1.2M | 21.46 |
| 2023-09-30 | $26M | 1.2M | 20.63 |
| 2023-06-30 | $47M | 1.6M | 29.51 |
| 2023-03-31 | $38M | 1.7M | 23.04 |
| 2022-12-31 | $49M | 1.8M | 27.81 |
| 2022-09-30 | $57M | 1.9M | 30.69 |
| 2022-06-30 | $58M | 2.0M | 29.43 |
| 2022-03-31 | $84M | 2.6M | 32.17 |
| 2021-12-31 | $129M | 2.9M | 44.60 |
| 2021-09-30 | $141M | 2.8M | 50.45 |
| 2021-06-30 | $222M | 2.8M | 78.44 |
| 2021-03-31 | $172M | 3.0M | 57.10 |
| 2020-12-31 | $270M | 3.2M | 83.76 |
| 2020-09-30 | $119M | 3.3M | 35.83 |
| 2020-06-30 | $82M | 3.4M | 24.18 |
| 2020-03-31 | $57M | 3.3M | 17.51 |
| 2019-03-31 | $14k | 596 | 23.49 |
| 2018-12-31 | $16k | 787 | 20.33 |
| 2018-09-30 | $278k | 13k | 21.71 |
| 2018-06-30 | $208k | 14k | 15.28 |
| 2018-03-31 | $269k | 14k | 19.66 |
| 2017-12-31 | $237k | 15k | 15.66 |